+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Left Atrial Appendage Occlusion for Secondary Stroke Prevention in Patients with Atrial Fibrillation: Long-Term Results



Left Atrial Appendage Occlusion for Secondary Stroke Prevention in Patients with Atrial Fibrillation: Long-Term Results



Cerebrovascular Diseases 47(3-4): 188-195



Patients surviving an initial stroke present a significantly increased risk for further strokes. Left atrial appendage closure (LAAC) became an alternative treatment to pharmacological therapy for stroke prevention in atrial fibrillation (AF) patients. To evaluate the long-term efficacy of LAAC in primary and secondary stroke prevention in patients with AF. This retrospective study enrolled 139 patients following LAAC who were divided into 2 groups: 37 patients with prior stroke (Stroke Group) and 102 patients without stroke (Control Group). Overall, cumulative follow-up was 530.1 patient-years. Mean CHADS2, CHA2DS2-VASc scores, and HAS-BLED score were higher in patients with prior stroke compared to patients without stroke (3.0 vs. 1.4, p < 0.0001 and 4.6 vs. 2.3, p < 0.0001, 4.0 vs. 2.8, p < 0.0001, respectively). There were no significant differences between other patient factors (sex, heart failure, hypertension, previous stroke/transient ischemic attack, peripheral vascular disease), which may increase the risk of thromboembolism based on the CHA2DS2-VASc score. Average follow-up was 51.3 months in patients with previous stroke and 50 months in patients without previous stroke. Thromboembolic event rate was 0.8 vs. 0.5 (p = 0.72), bleeding event rate was 0 years vs. 1.4 (p = 0.25), and mortality rates were 0.8 vs. 2.1 (p = 0.38) between the Stroke Group and the Control Group. The estimated reductions in thromboembolic and bleeding risks were 89 and 100%, respectively, in Stroke Group, and 91 and 81%, respectively, in Control Group. Patients with prior stroke may be the preferred group for LAAC regardless of the presence or absence of contraindications for anticoagulant therapy.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066813416

Download citation: RISBibTeXText

PMID: 31121584

DOI: 10.1159/000500850


Related references

Left atrial appendage occlusion for stroke prevention in diabetes mellitus patients with atrial fibrillation: Long-term results. Journal of Diabetes 11(1): 75-82, 2019

Thoracoscopic Left Atrial Appendage Occlusion for Stroke Prevention Compared with Long-Term Warfarin Therapy in Patients With Nonvalvular Atrial Fibrillation. American Journal of Cardiology 123(1): 50-56, 2019

Left atrial appendage occluder implantation for stroke prevention in elderly patients with atrial fibrillation: acute and long-term results. Journal of Geriatric Cardiology 14(9): 590-592, 2017

Transcatheter left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: results from the Belgian registry. Eurointervention 13(13): 1603-1611, 2018

Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention. American Heart Journal 145(1): 174-178, 2003

The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. Journal of the American College of Cardiology 59(10): 923-929, 2012

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Expert Review of Cardiovascular Therapy 13(8): 907-914, 2015

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Clinical Cardiology 40(10): 825-831, 2017

Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Atrial Fibrillation. Interventional Cardiology Clinics 7(2): Xiii, 2018

Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Nonrheumatic Atrial Fibrillation. Journal of Atrial Fibrillation 6(3): 923, 2013

Transcatheter left atrial appendage occlusion in the prevention of stroke and death in patients with atrial fibrillation. Kardiologia Polska 72(11): 1127-1134, 2014

Left atrial appendage occlusion for stroke prevention in atrial fibrillation in Europe: results of the European Heart Rhythm Association survey. Europace 15(1): 141-143, 2013

Left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: ready for the prime time?. Expert Review of Cardiovascular Therapy 11(12): 1587-1589, 2013

Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation. Revue Neurologique 171(5): 426-432, 2015

The case of stroke prevention by left atrial appendage occlusion in patients with atrial fibrillation-can we close the file?. Journal of Thoracic Disease 7(10): 1696-1698, 2015